ClinicalTrials.Veeva

Menu

Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection (IRPOL)

U

University Hospital, Rouen

Status

Enrolling

Conditions

Lung Cancer

Treatments

Other: rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06202222
2020/0427/HP

Details and patient eligibility

About

For patients diagnosed with non-small cell lung cancer (NSCLC), lung resection surgery remains the gold standard for curative treatment. This scheduled operation is associated with significant morbidity, particularly in individuals with impaired cardio-respiratory function. Therefore, patient optimization is paramount. The process begins prior to surgery with preoperative rehabilitation, commonly referred to as "prehabilitation," serving as the foundation for various Enhanced Recovery After Surgery programs. The training methods employed in these programs bear similarity to rehabilitation programs designed for patients with chronic obstructive pulmonary disease (COPD).

Postoperatively, patients undergoing thoracic surgery partake in daily physiotherapy sessions, aiming to optimize the postoperative period, minimize the respiratory impact of surgery, and reduce the length of hospital stay. However, this treatment is not currently standardized and primarily involves early mobilization, including walking, and respiratory physiotherapy. Our focus is on the intensity and methods of this postoperative rehabilitation.

There is limited literature on effective early rehabilitation in the immediate postoperative period, and existing studies suggest no adverse events associated with postoperative training. Therefore, our objective is to assess whether combining endurance training with standard physiotherapy (walking and respiratory physiotherapy) enhances the functional capacity of individuals undergoing lung surgery.

Enrollment

184 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients requiring surgery for diagnosed or undergoing diagnosis of lung cancer.
  • Patients in need of major lung resection through a minimally invasive approach.
  • Patients capable of performing the chair rise test.

Exclusion criteria

- Contraindications to cyclo-ergometry: Deep vein thrombosis in a lower limb. Patients with one or both lower limbs amputated. Rheumatological pathology, trauma, or previous surgery in the lower limb, pelvis, or spine, resulting in limited joint amplitude or strict immobilization.

Dermatological conditions with severe lesions preventing prolonged sitting on a bicycle.

  • Glasgow score less than 15.
  • Patients who have not undergone pulmonary resection by minimally invasive surgery.
  • Patients hospitalized outside the thoracic surgery department before the first post-operative visit with the physiotherapist on Day 0.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

184 participants in 2 patient groups

standard rehabilitation
No Intervention group
standard rehabilitation and cycloergometer
Experimental group
Treatment:
Other: rehabilitation

Trial contacts and locations

3

Loading...

Central trial contact

Jean-Marc BASTE, PhD; Fairuz BOUJIBAR, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems